{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OPP-2008-0687-0020", "EPA", "EPA-HQ-OPP-2008-0687", "Letter from Edward Cox, MD, MPH, Director, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA) to Michael L. Goodis, P.E., Director, Registration Division, Office of Pesticide Programs, U.S. Environmental Protection Agency (EPA) dated April 6, 2018", "Supporting & Related Material", "Letter", "2019-03-18T04:00:00Z", 2019, 3, null, null, "2019-03-18T21:45:10Z", null, 0, 0, "09000064839ca587"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OPP-2008-0687-0020"], "units": {}, "query_ms": 11.0908520873636, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}